MeSH D003457 - cryptosporidiosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| ANI Pharmaceuticals | Nitazoxanide | Nitazoxanide |  | 2025-02-03 |  |  |
| Annora Pharma | Nitazoxanide | Nitazoxanide |  | 2025-04-15 |  |  |
| Heritage Pharmaceuticals | Paromomycin | Paromomycin |  | 2007-12-14 |  |  |
| King Pharmaceuticals | Paromomycin | Humatin |  | 1982-01-01 |  |  |
| Parkedale Pharmaceuticals | Paromomycin | Humatin |  | 1982-01-01 |  |  |
| Pfizer | Paromomycin | Humatin |  | 1982-01-01 |  |  |
| Rising Pharmaceuticals | Nitazoxanide | Nitazoxanide |  | 2020-11-27 |  |  |
| Romark Laboratories L.c. | Nitazoxanide | Alinia |  | 2004-07-21 |  |  |
| Sun Pharmaceutical Industries | Paromomycin | Paromomycin |  | 1997-06-30 |  |  |
Clinical Trials
Historical Success Rate
Phase 1
50%1/2
Phase 2
33%1/3
Phase 3
100%3/3
Approved: 2Overall Success rate: 17%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use